Market resilience of orthopaedic hip/knee arthroplasty sales during COVID-19.
Mitchell K NgAndy KuoPatrick P NianWilliam J KridelAfshin E RaziChe Hang Jason WongMichael A MontNicolas S PiuzziPublished in: Archives of orthopaedic and trauma surgery (2024)
Similar to the overall market and healthcare sector, the top five hip/knee arthroplasty companies have recovered from their COVID market lows. Our results reveal that the valuations of hip/knee companies remained robust during COVID, even as revenues fell, likely due to strong investor confidence in the industry outlook and the greater overall healthcare system utilization.